1. Home
  2. CYTK vs RDNT Comparison

CYTK vs RDNT Comparison

Compare CYTK & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • RDNT
  • Stock Information
  • Founded
  • CYTK 1997
  • RDNT 1985
  • Country
  • CYTK United States
  • RDNT United States
  • Employees
  • CYTK N/A
  • RDNT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • RDNT Medical Specialities
  • Sector
  • CYTK Health Care
  • RDNT Health Care
  • Exchange
  • CYTK Nasdaq
  • RDNT Nasdaq
  • Market Cap
  • CYTK 5.7B
  • RDNT 6.0B
  • IPO Year
  • CYTK 2004
  • RDNT 1986
  • Fundamental
  • Price
  • CYTK $45.82
  • RDNT $60.19
  • Analyst Decision
  • CYTK Buy
  • RDNT Strong Buy
  • Analyst Count
  • CYTK 15
  • RDNT 4
  • Target Price
  • CYTK $83.64
  • RDNT $79.75
  • AVG Volume (30 Days)
  • CYTK 1.1M
  • RDNT 687.2K
  • Earning Date
  • CYTK 02-25-2025
  • RDNT 02-27-2025
  • Dividend Yield
  • CYTK N/A
  • RDNT N/A
  • EPS Growth
  • CYTK N/A
  • RDNT N/A
  • EPS
  • CYTK N/A
  • RDNT N/A
  • Revenue
  • CYTK $3,219,000.00
  • RDNT $1,772,946,000.00
  • Revenue This Year
  • CYTK N/A
  • RDNT $14.81
  • Revenue Next Year
  • CYTK $710.83
  • RDNT $8.84
  • P/E Ratio
  • CYTK N/A
  • RDNT N/A
  • Revenue Growth
  • CYTK N/A
  • RDNT 12.20
  • 52 Week Low
  • CYTK $44.49
  • RDNT $35.16
  • 52 Week High
  • CYTK $84.92
  • RDNT $93.65
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 39.27
  • RDNT 22.35
  • Support Level
  • CYTK $44.49
  • RDNT $57.94
  • Resistance Level
  • CYTK $48.45
  • RDNT $68.18
  • Average True Range (ATR)
  • CYTK 1.65
  • RDNT 2.97
  • MACD
  • CYTK -0.08
  • RDNT -1.10
  • Stochastic Oscillator
  • CYTK 23.50
  • RDNT 14.71

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

Share on Social Networks: